CD7-targeted CAR-T cell therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD7-targeted CAR-T cell therapy, covering 2024-11-21 to 2024-11-21. Get the full timeline:
Most recent: Clinical Trial Update: Research Development（RD）13-02 Chimeric Antigen Receptor(CAR) -T Cell Injection for Patients With r/r Cluster Of Differentiation 7（CD7）+ T-Acute Lymphoblastic Leukemia(ALL)/T-Lymphoblastic Lymphoma(LBL) /Acute Myelogenous Leukemia(AML) [EARLY_Phase 1]